- Home
- FOLD vs ADX Comparison
FOLD vs ADX Comparison
Compare FOLD & ADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- ADX
- Stock Information
- Founded
- FOLD 2002
- ADX 1840
- Country
- FOLD United States
- ADX United States
- Employees
- FOLD N/A
- ADX N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- ADX Investment Managers
- Sector
- FOLD Health Care
- ADX Finance
- Exchange
- FOLD Nasdaq
- ADX Nasdaq
- Market Cap
- FOLD 2.9B
- ADX 2.3B
- IPO Year
- FOLD 2007
- ADX N/A
- Fundamental
- Price
- FOLD $6.08
- ADX $19.34
- Analyst Decision
- FOLD Buy
- ADX
- Analyst Count
- FOLD 10
- ADX 0
- Target Price
- FOLD $16.22
- ADX N/A
- AVG Volume (30 Days)
- FOLD 4.6M
- ADX 182.4K
- Earning Date
- FOLD 05-01-2025
- ADX 01-01-0001
- Dividend Yield
- FOLD N/A
- ADX 6.68%
- EPS Growth
- FOLD N/A
- ADX N/A
- EPS
- FOLD N/A
- ADX N/A
- Revenue
- FOLD $543,141,000.00
- ADX N/A
- Revenue This Year
- FOLD $21.87
- ADX N/A
- Revenue Next Year
- FOLD $22.19
- ADX N/A
- P/E Ratio
- FOLD N/A
- ADX N/A
- Revenue Growth
- FOLD 28.25
- ADX N/A
- 52 Week Low
- FOLD $6.20
- ADX $14.94
- 52 Week High
- FOLD $12.65
- ADX $19.57
- Technical
- Relative Strength Index (RSI)
- FOLD 29.58
- ADX 57.82
- Support Level
- FOLD $6.63
- ADX $19.00
- Resistance Level
- FOLD $7.71
- ADX $19.44
- Average True Range (ATR)
- FOLD 0.30
- ADX 0.30
- MACD
- FOLD -0.05
- ADX 0.12
- Stochastic Oscillator
- FOLD 13.76
- ADX 93.83
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally-managed closed-end fund. The investment objectives of the company are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It has a diversified equity portfolio which consists of securities of companies from Energy, Consumer Staples, Information Technology, Financials and other sectors.